Loading...
Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
INTRODUCTION: Recent years have seen a dramatic escalation of off-label prescribing for gabapentin and pregabalin (gabapentinoids) owing in part to generic versions of each being released over the past two decades, but also in part as a response to increasing calls for multimodal and non-opioid pain...
Na minha lista:
| Udgivet i: | Pain Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Healthcare
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7648827/ https://ncbi.nlm.nih.gov/pubmed/32737803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40122-020-00189-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|